• Press Releases

SetPoint Medical Announces FDA Approval for Continuation of the RESET-RA Pivotal Study

Read Press Release from
September 13, 2022

SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs

Read Press Release from
November 3, 2021

Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical

Read Press Release from
July 13, 2021

SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows

Read Press Release from
March 3, 2021

SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study

Read Press Release from
February 1, 2021

SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectro...

Read Press Release from
January 27, 2021

SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform

Read Press Release from
October 6, 2020

The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile f...

Read Press Release from
July 29, 2020

SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheuma...

Read Press Release from
May 6, 2020

SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019

Read Press Release from
November 14, 2019

SetPoint Medical Announces Oral Presentation of Results from U.S. Pilot Study in Rheumatoid Arthritis Patie...

Read Press Release from
October 29, 2019

SetPoint Medical Reports Positive Results from its U.S. Pilot Study in Rheumatoid Arthritis

Read Press Release from
June 17, 2019